Your search returned 2819 results.

Results
	2801.	Treatment of unresectable cholangiocarcinoma with gemcitabine-based transcatheter arterial chemoembolization (TACE): a single-institution experience. [electronic resource] by Gusani, Niraj J Balaa, Fady K Steel, Jennifer L Geller, David A Marsh, J Wallis Zajko, Albert B Carr, Brian I Gamblin, T Clark Producer: 20080520 In: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2802.	Genetic polymorphism of XRCC1 Arg399Gln is associated with survival in non-small-cell lung cancer patients treated with gemcitabine/platinum. [electronic resource] by Liao, Wei-Yu Shih, Jin-Yuan Chang, Gee-Chen Cheng, Yu-Kai Yang, James Chih-Hsin Chen, Yuh-Min Yu, Chong-Jen Producer: 20120925 In: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2803.	Identification of RNR4, encoding a second essential small subunit of ribonucleotide reductase in Saccharomyces cerevisiae. [electronic resource] by Huang, M Elledge, S J Producer: 19971023 In: Molecular and cellular biology vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2804.	γ-H2AX kinetics as a novel approach to high content screening for small molecule radiosensitizers. [electronic resource] by Fu, Shibo Yang, Ying Das, Tirtha K Tirtha, Das Yen, Yun Zhou, Bing-sen Zhou, Ming-Ming Ohlmeyer, Michael Ko, Eric C Cagan, Ross Rosenstein, Barry S Chen, Shu-hsia Kao, Johnny Producer: 20121127 In: PloS one vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2805.	A novel human gene similar to the protein kinase (PK) coding domain of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) codes for a serine-threonine PK and is expressed in melanoma cells. [electronic resource] by Smith, C C Yu, Y X Kulka, M Aurelian, L Producer: 20000921 In: The Journal of biological chemistry vol. 275 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2806.	Mouse models of oxidative phosphorylation dysfunction and disease. [electronic resource] by Vempati, Uma D Torraco, Alessandra Moraes, Carlos T Producer: 20090121 In: Methods (San Diego, Calif.) vol. 46 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2807.	The herpes simplex virus type 2 R1 protein kinase (ICP10 PK) blocks apoptosis in hippocampal neurons, involving activation of the MEK/MAPK survival pathway. [electronic resource] by Perkins, D Pereira, E F R Gober, M Yarowsky, P J Aurelian, L Producer: 20020212 In: Journal of virology vol. 76 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2808.	A combination of a ribonucleotide reductase inhibitor and histone deacetylase inhibitors downregulates EGFR and triggers BIM-dependent apoptosis in head and neck cancer. [electronic resource] by Stauber, Roland H Knauer, Shirley K Habtemichael, Negusse Bier, Carolin Unruhe, Britta Weisheit, Simona Spange, Stephanie Nonnenmacher, Frank Fetz, Verena Ginter, Torsten Reichardt, Sigrid Liebmann, Claus Schneider, Günter Krämer, Oliver H Producer: 20120702 In: Oncotarget vol. 3 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2809.	A small-molecule blocking ribonucleotide reductase holoenzyme formation inhibits cancer cell growth and overcomes drug resistance. [electronic resource] by Zhou, Bingsen Su, Leila Hu, Shuya Hu, Weidong Yip, M L Richard Wu, Jun Gaur, Shikha Smith, D Lynne Yuan, Yate-Ching Synold, Timothy W Horne, David Yen, Yun Producer: 20140107 In: Cancer research vol. 73 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2810.	Resveratrol induces apoptosis in K562 (chronic myelogenous leukemia) cells by targeting a key survival protein, heat shock protein 70. [electronic resource] by Chakraborty, Prabir K Mustafi, Soumyajit Banerjee Ganguly, Sudipto Chatterjee, Mitali Raha, Sanghamitra Producer: 20080619 In: Cancer science vol. 99 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2811.	Effect of chemotherapy-induced DNA repair on oncolytic herpes simplex viral replication. [electronic resource] by Aghi, Manish Rabkin, Samuel Martuza, Robert L Producer: 20060112 In: Journal of the National Cancer Institute vol. 98 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2812.	v-Abl utilizes multiple mechanisms to drive G1/S progression in fibroblasts. [electronic resource] by Coutts, M Zou, X Calame, K Producer: 20000316 In: Oncogene vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2813.	RRM1 domain of the splicing oncoprotein SRSF1 is required for MEK1-MAPK-ERK activation and cellular transformation. [electronic resource] by Shimoni-Sebag, Ariel Lebenthal-Loinger, Ilana Zender, Lars Karni, Rotem Producer: 20140122 In: Carcinogenesis vol. 34 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2814.	Hydroxyurea decreases gemcitabine resistance in pancreatic carcinoma cells with highly expressed ribonucleotide reductase. [electronic resource] by Funamizu, Naotake Kamata, Yuko Misawa, Takeyuki Uwagawa, Tadashi Lacy, Curtis Ray Yanaga, Katsuhiko Manome, Yoshinobu Producer: 20120522 In: Pancreas vol. 41 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2815.	Optimization for the blockade of epidermal growth factor receptor signaling for therapy of human pancreatic carcinoma. [electronic resource] by Solorzano, C C Baker, C H Tsan, R Traxler, P Cohen, P Buchdunger, E Killion, J J Fidler, I J Producer: 20011018 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 7 Availability: No items available. Save to lists Add to cart (remove)
	2816.	Flavopiridol increases sensitization to gemcitabine in human gastrointestinal cancer cell lines and correlates with down-regulation of ribonucleotide reductase M2 subunit. [electronic resource] by Jung, C P Motwani, M V Schwartz, G K Producer: 20011018 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 7 Availability: No items available. Save to lists Add to cart (remove)
	2817.	LY2109761, a novel transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis. [electronic resource] by Melisi, Davide Ishiyama, Satoshi Sclabas, Guido M Fleming, Jason B Xia, Qianghua Tortora, Giampaolo Abbruzzese, James L Chiao, Paul J Producer: 20080718 In: Molecular cancer therapeutics vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2818.	Multi-targeted neuroprotection by the HSV-2 gene ICP10PK includes robust bystander activity through PI3-K/Akt and/or MEK/ERK-dependent neuronal release of vascular endothelial growth factor and fractalkine. [electronic resource] by Laing, Jennifer M Smith, Cynthia C Aurelian, Laure Producer: 20100216 In: Journal of neurochemistry vol. 112 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2819.	Cross-species genomic and functional analyses identify a combination therapy using a CHK1 inhibitor and a ribonucleotide reductase inhibitor to treat triple-negative breast cancer. [electronic resource] by Bennett, Christina N Tomlinson, Christine C Michalowski, Aleksandra M Chu, Isabel M Luger, Dror Mittereder, Lara R Aprelikova, Olga Shou, James Piwinica-Worms, Helen Caplen, Natasha J Hollingshead, Melinda G Green, Jeffrey E Producer: 20150624 In: Breast cancer research : BCR vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)